The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Precision Cancer Therapies Market Research Report 2024
Synopsis
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
The global Precision Cancer Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapies.
Report Scope
The Precision Cancer Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Segment by Type
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Segment by Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Precision cancer therapies is an evolving approach to cancer care that aims to leverage new knowledge regarding the pathogenesis of cancer to more precisely target therapy.
The global Precision Cancer Therapies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Precision Cancer Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Therapies.
Report Scope
The Precision Cancer Therapies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Precision Cancer Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Bayer HealthCare
GlaxoSmithKline
OncoGenex Pharmaceuticals
Hospira
Boehringer Ingelheim
AstraZeneca
Aveo Pharmaceuticals
Segment by Type
Hormone Therapy
Immunotherapies
Targeted Therapy
Monoclonal Antibody Therapy
Gene Therapy
Segment by Application
Hospitals
Diagnostic Centers
Oncology Clinics
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hormone Therapy
1.2.3 Immunotherapies
1.2.4 Targeted Therapy
1.2.5 Monoclonal Antibody Therapy
1.2.6 Gene Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Therapies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Oncology Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapies Market Perspective (2019-2030)
2.2 Precision Cancer Therapies Growth Trends by Region
2.2.1 Global Precision Cancer Therapies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Precision Cancer Therapies Historic Market Size by Region (2019-2024)
2.2.3 Precision Cancer Therapies Forecasted Market Size by Region (2025-2030)
2.3 Precision Cancer Therapies Market Dynamics
2.3.1 Precision Cancer Therapies Industry Trends
2.3.2 Precision Cancer Therapies Market Drivers
2.3.3 Precision Cancer Therapies Market Challenges
2.3.4 Precision Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapies Players by Revenue
3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2019-2024)
3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2019-2024)
3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
3.4 Global Precision Cancer Therapies Market Concentration Ratio
3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2023
3.5 Precision Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Precision Cancer Therapies Product Solution and Service
3.7 Date of Enter into Precision Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapies Breakdown Data by Type
4.1 Global Precision Cancer Therapies Historic Market Size by Type (2019-2024)
4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2025-2030)
5 Precision Cancer Therapies Breakdown Data by Application
5.1 Global Precision Cancer Therapies Historic Market Size by Application (2019-2024)
5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Precision Cancer Therapies Market Size (2019-2030)
6.2 North America Precision Cancer Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Precision Cancer Therapies Market Size by Country (2019-2024)
6.4 North America Precision Cancer Therapies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Precision Cancer Therapies Market Size (2019-2030)
7.2 Europe Precision Cancer Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Precision Cancer Therapies Market Size by Country (2019-2024)
7.4 Europe Precision Cancer Therapies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapies Market Size (2019-2030)
8.2 Asia-Pacific Precision Cancer Therapies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Precision Cancer Therapies Market Size by Region (2019-2024)
8.4 Asia-Pacific Precision Cancer Therapies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Precision Cancer Therapies Market Size (2019-2030)
9.2 Latin America Precision Cancer Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Precision Cancer Therapies Market Size by Country (2019-2024)
9.4 Latin America Precision Cancer Therapies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapies Market Size (2019-2030)
10.2 Middle East & Africa Precision Cancer Therapies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Precision Cancer Therapies Market Size by Country (2019-2024)
10.4 Middle East & Africa Precision Cancer Therapies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Detail
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2019-2024)
11.2.5 Bayer HealthCare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 OncoGenex Pharmaceuticals
11.4.1 OncoGenex Pharmaceuticals Company Detail
11.4.2 OncoGenex Pharmaceuticals Business Overview
11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2019-2024)
11.4.5 OncoGenex Pharmaceuticals Recent Development
11.5 Hospira
11.5.1 Hospira Company Detail
11.5.2 Hospira Business Overview
11.5.3 Hospira Precision Cancer Therapies Introduction
11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2019-2024)
11.5.5 Hospira Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2019-2024)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Precision Cancer Therapies Introduction
11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 Aveo Pharmaceuticals
11.8.1 Aveo Pharmaceuticals Company Detail
11.8.2 Aveo Pharmaceuticals Business Overview
11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2019-2024)
11.8.5 Aveo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
